E3 ligase Trim63 promotes the chondrogenic differentiation of mesenchymal stem cells by catalyzing K27-linked cysteine ubiquitination of Myh11
Stem Cells · 2025
DOI: 10.1093/stmcls/sxaf017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cells, 2025. Verfasst von Shanyu Ye und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen 518101 Guangdong, People's Republic of China. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Ubiquitination, Cell Differentiation, Chondrogenesis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Shenzhen Science and Technology Program, Research Topic of Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Sanming Project of Medicine in Shenzhen.
Abstract (Originalsprache)
Mesenchymal stem cells (MSCs) are multipotent stem cells that have a chondrogenic differentiation capacity. However, the molecular mechanism underlying the chondrogenic differentiation of MSCs has not been fully elucidated, which hinders further development of MSC-based cell therapies for cartilage repair in the clinic. Here, we showed that the E3 ubiquitin ligase Trim63 positively regulates the chondrogenic differentiation of MSCs by catalyzing the K27-linked cysteine ubiquitination of Myh11. Trim63 directly interacts with Myh11 and catalyzes K27-linked ubiquitination of cys382. Mutation of cys382 diminishes Trim63-catalyzed K27-linked ubiquitination and chondrogenic differentiation of MSCs. A deficiency in Trim63 significantly impairs the chondrogenic differentiation of MSCs. Trim63 enhances the repair of articular cartilage defects in vivo. Taken together, the results of our study demonstrated that Trim63 promotes the chondrogenic differentiation of MSCs by catalyzing K27-linked cysteine ubiquitination of Myh11, which provides an alternative therapeutic target for cartilage regeneration and repair.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen 518101 Guangdong, People's Republic of China.
- Guangzhou Pharmaceutical Vocational School, Guangzhou 511370, Guangdong, People's Republic of China.
- Department of Anatomy, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, People's Republic of China.
- School of Chinese Herbal Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, People's Republic of China.
- Department of Histology and Embryology, Southern Medical University, Guangzhou 510515, People's Republic of China.
- RNA Biomedical Institute, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, People's Republic of China.
ORCID-Profile: Helu Liu
Förderung
- Shenzhen Science and Technology Program
- Research Topic of Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine
- Sanming Project of Medicine in Shenzhen
- Natural Science Foundation of Guangdong Province China
- Medical Scientific Research foundation of Guangdong Province
Zitieren
APA
Ye, S., Wang, Y., Luo, Z., Liu, A., Li, X., Guo, J., Zhao, W., Chen, D., Yang, L., & Liu, H. (2025). E3 ligase Trim63 promotes the chondrogenic differentiation of mesenchymal stem cells by catalyzing K27-linked cysteine ubiquitination of Myh11. Stem Cells. https://doi.org/10.1093/stmcls/sxaf017
Vancouver
Ye S, Wang Y, Luo Z, Liu A, Li X, Guo J, et al. E3 ligase Trim63 promotes the chondrogenic differentiation of mesenchymal stem cells by catalyzing K27-linked cysteine ubiquitination of Myh11. Stem Cells. 2025. doi:10.1093/stmcls/sxaf017
BibTeX
@article{Ye2025,
author = {Ye, Shanyu and Wang, Yanqing and Luo, Ziwei and Liu, Aijun and Li, Xican and Guo, Jiasong and Zhao, Wei and Chen, Dongfeng and Yang, Lin and Liu, Helu},
title = {E3 ligase Trim63 promotes the chondrogenic differentiation of mesenchymal stem cells by catalyzing K27-linked cysteine ubiquitination of Myh11},
journal = {Stem Cells},
year = {2025},
doi = {10.1093/stmcls/sxaf017}
}
EUVIMED